Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The louse exoskeleton is a multilayered external structure primarily composed of chitin (a polysaccharide) and diverse cuticular proteins. In lice, as in other insects, it provides rigidity, mechanical support, protection against desiccation, and serves as the interface for interaction with the environment[1][4]. Key structural proteins identified in the head louse nit sheath (the protective covering of louse eggs) include louse nit sheath protein 1 (LNSP1) and louse nit sheath protein 2 (LNSP2), with high content of glycine, glutamine/glutamic acid, alanine, and valine residues[2][3]. Protein cross-linking (mediated by enzymes like transglutaminase) and sclerotization processes further harden and strengthen the exoskeleton[1][4]. Chemically, the exoskeleton's cuticle is a composite of chitin polymers and structural proteins; regions can be further stiffened by sclerotization (protein cross-linking) or, in other arthropods, biomineralization—but in lice it is almost purely organic with minimal mineralization[4]. Unlike classical drug targets, therapies for lice infestations act by physically or chemically compromising the integrity of the exoskeleton, rather than targeting a specific molecular entity[1][4]. "Louse exoskeleton" does not represent a discrete, canonical molecular target; it is an anatomical and functional barrier composed of biopolymers and proteins, essential for louse survival but not a target in the conventional pharmacological sense.
Physically disrupts or penetrates the exoskeleton to kill lice (e.g., by blocking spiracles causing asphyxiation, dissolving or disrupting the cuticle, or inhibiting neural function through action on the nervous system after penetrating the exoskeleton)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Louse exoskeleton.